Greenamyre lab
Last Posted: Dec 04, 2018
- A paradoxical relationship between family history, onset age, and genetic risk in Parkinson's disease.
Kristiansen Madeleine et al. Movement disorders : official journal of the Movement Disorder Society 2018 Nov - Direct-To-Consumer Genetic Testing: Is the Public Ready for Simple, At-Home DNA Tests to Detect Disease Risk?
Bates Mary et al. IEEE pulse 9(6) 11-14 - Largest genome-wide association study for PTSD identifies genetic risk loci in European and African ancestries and implicates novel biological pathways
BioRXIV preprints, November 1, 2018 - Pharmacogenetics and levodopa induced motor complications.
Kalinderi Kallirhoe et al. The International journal of neuroscience 2018 Oct 1-31 - Recent Advances in Biomarkers for Parkinson's Disease.
He Runcheng et al. Frontiers in aging neuroscience 2018 10305 - Mendelian Randomization Studies of Coffee and Caffeine Consumption.
Cornelis Marilyn C et al. Nutrients 2018 Sep 10(10) - Pharmacogenomics of Alzheimer's and Parkinson's diseases.
Cacabelos Ramón et al. Neuroscience letters 2018 Sep - Decoding Your DNA: What to Consider Before Genetic Testing
K Hobson, US News, September, 2018 - [FROM GENETICS OF FRAGILE X SYNDROME TO DEVELOPMENT OF TARGETED AND PERSONALIZED DRUG THERAPY].
Gabis Lidia V et al. Harefuah 2018 Aug 157(8) 529-533 - Self-report data as a tool for subtype identification in genetically-defined Parkinson's Disease.
Winslow Ashley R et al. Scientific reports 2018 Aug 8(1) 12992
No hay comentarios:
Publicar un comentario